Serial Number
99270242
Owner
Eterna Technologies CorporationAttorney
Thomas DietrichFiling Date
Jul 7, 2025
NOHO LABS Trademark
Serial Number: 99270242
Trademark Classes
Owner Contact Info
Pier 5, Ste. 101
San Francisco, CA 94111
Entity Type: 03
Legal Representation
Correspondence Address
Thomas Dietrich The McArthur Law Firm, PC
8383 Wilshire Blvd., Suite 800
Beverly Hills, CA 90211
United States
Trademark Details
Filing Date
July 7, 2025
Registration Date
Not Registered
Published for Opposition
March 10, 2026
Goods & Services
Telemedicine services; Health care services for treating aging and loss of biological function through peptide therapy; Providing personalized healthcare and medical information in the nature of peptide therapy; Health care services, namely, peptide therapy; Health care consulting in the field of peptide therapy; Providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling
Pharmaceutical preparations for peptide therapy for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Syringes sold filled with peptide preparations for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Pharmaceutical preparations for skin care; Therapeutic pharmaceutical for the treatment of aging, hormone imbalance, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment of aging-related conditions, hormone imbalances, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment and prevention of aging-related conditions; Diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; Synthetic peptides for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes